NINE MONTHS RESULTS
Venus Remedies Ltd.
BSE
Apr 30
304.85
-6.30 ( -2.02%)
Volume
1078
Prev. Close
311.15
Open Price
315.35
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
302.85
-8.70 ( -2.79%)
Volume
22329
Prev. Close
311.55
Open Price
315.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Nine Months Results
for the last 5 years.
|
ISIN No
|
INE411B01019
|
Market Cap. ( ₹ in Cr. )
|
404.82
|
P/BV
|
0.82
|
Book Value ( ₹ )
|
369.73
|
|
BSE Code
|
526953
|
52 Week High/Low ( ₹ )
|
428/270
|
FV/ML
|
10/1
|
P/E(X)
|
14.21
|
|
NSE Code
|
VENUSREMEQ
|
Book Closure
|
23/09/2024
|
EPS ( ₹ )
|
21.31
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Net Sales/Income from operations | 445.42 | 400.05 | 389.13 | 446.93 | 412.18 |
| Total Income From Operations | 445.42 | 400.05 | 389.13 | 446.93 | 412.18 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 244.61 | 254.61 | 243.93 | 286.01 | 264.54 |
| Purchase of Traded Goods | 22.91 | 10.40 | 3.93 | 0.00 | 0.00 |
| Increase/Decrease in Stocks | 4.93 | -17.79 | -1.95 | 3.37 | 4.62 |
| Employees Cost | 52.92 | 44.92 | 39.61 | 32.04 | 27.57 |
| Depreciation | 17.13 | 19.84 | 23.31 | 25.23 | 25.10 |
| Admin. And Selling Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 64.96 |
| ResearchAndDevlopmentExpenses | 0.00 | 0.00 | 0.00 | 0.00 | 11.51 |
| Other Expenses | 72.61 | 68.30 | 63.11 | 63.99 | 0.00 |
| Total Expenses | 415.11 | 380.28 | 371.94 | 410.63 | 398.29 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 30.31 | 19.77 | 17.19 | 36.30 | 13.89 |
| Other Income | 14.01 | 7.41 | 6.93 | 5.95 | 14.40 |
| P/L Before Interest, Excpt. Items & Tax | 44.32 | 27.18 | 24.12 | 42.25 | 28.29 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 11.86 |
| P/L Before Exceptional Items & Tax | 44.32 | 27.18 | 24.12 | 42.25 | 16.43 |
| Exceptional Items | 9.91 | 0.00 | 0.00 | 0.00 | 2.89 |
| P/L Before Tax | 54.23 | 27.18 | 24.12 | 42.25 | 19.32 |
| Tax | 16.46 | 9.20 | 2.69 | -4.31 | 3.70 |
| P/L After Tax from Ordinary Activities | 37.77 | 17.98 | 21.43 | 46.57 | 15.62 |
| Net Profit/Loss For the Period | 37.77 | 17.98 | 21.43 | 46.57 | 15.62 |
| | | | | | |
| Equity Share Capital | 13.37 | 13.37 | 13.37 | 13.37 | 12.34 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 28.25 | 13.45 | 16.03 | 35.29 | 12.66 |
| Diluted EPS (Rs.) | 28.25 | 13.45 | 16.03 | 35.29 | 12.66 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 28.25 | 13.45 | 16.03 | 35.29 | 12.66 |
| Diluted EPS (Rs.) | 28.25 | 13.45 | 16.03 | 35.29 | 12.66 |
| | | | | | |
| PBITOE Margin (%) | 6.80 | 4.94 | 4.41 | 8.12 | 3.37 |
| PBTE Margin (%) | 9.95 | 6.79 | 6.19 | 9.45 | 3.98 |
| PBT Margin (%) | 12.17 | 6.79 | 6.19 | 9.45 | 4.68 |
| PAT Margin (%) | 8.47 | 4.49 | 5.50 | 10.41 | 3.79 |